ba0003oc2.2 | Osteoporosis epidemiology | ECTS2014
van Wijngaarden JP
, Swart KMA
, Enneman AW
, Dhonukshe-Rutten RAM
, van Dijk SC
, Ham AC
, Brouwer-Brolsma EM
, van der Zwaluw NL
, Sohl E
, van Meurs JBJ
, Zillikens MC
, van Schoor NM
, van der Velde N
, Brug J
, Uitterlinden AG
, Lips P
, de Groot CPGM
Background: Elevated plasma homocysteine levels are a risk factor for osteoporotic fractures. Supplementation with vitamin B12/folic acid lowers homocysteine levels. This study aimed to determine whether vitamin B12/folic acid supplementation reduces osteoporotic fracture incidence in hyperhomocysteinemic elderly.Methods: B-PROOF is a double-blind, randomized, placebo-controlled trial including 2 919 participants aged ≧65 years with elevated homocyste...